Jim Cramer Discusses the Performance of Danaher and Its Peers

Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer called it a “one-time excellent company,” as he said:

For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I should say a savage string of not-so-great quarters. The stock of the medical and diagnostic company is down… 27% year to date, and just head shaking, this is Danaher. Those two, of course, aren’t alone. Boston Scientific, Intuitive Surgical, Medtronic, ResMed, Stryker, Zimmer Biomet, they all hit new lows. That’s a remarkable confluence of true ugliness from some pretty darn good companies.

Photo by Adam Nowakowski on Unsplash

Danaher Corporation (NYSE:DHR) provides instruments, consumables, software, and services used in bioprocessing, life sciences research, and clinical diagnostics. Cramer mentioned the stock during the January 23 episode and commented:

CNBC Investing Club members, look out. You’re going to be flooded with emails Wednesday because Charitable Trust holdings, Danaher, Starbucks, GE Vernova, Microsoft, Meta, and Corning all report. Let me give you a preview. After a multi-year dry spell, Danaher has big orders from biotechs for expensive management. It seems like a biotech comes public every day, doesn’t it? They’ve managed some better-than-feared results in recent quarters, but this could be the first truly strong quarter in years. The stock was down badly today. Could be a real interesting opportunity.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.